← FDA Drug Approvals (Drugs@FDA)
ADAPALENE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS MID ATLANTIC · Approved 2014-10-27
Drug application
- FDA Application #
ANDA201000- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ADAPALENE
- Generic name
- ADAPALENE
- Active ingredients
- ADAPALENE
- Dosage form
- GEL
- Route
- TOPICAL
- Marketing status
- Prescription
- Sponsor
- ACTAVIS MID ATLANTIC
- Manufacturer
- Actavis Pharma, Inc.
- First approval
- 2014-10-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown